课题基金 / 基金详情

Role of chemokine CCL20 and its receptor CCR6 against bacterial infection.

Role of chemokine CCL20 and its receptor CCR6 against bacterial infection.
趋化因子 CCL20 及其受体 CCR6 对抗细菌感染的作用。
批准号:
15591070
负责人:
MATSUMURA Haruo
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

MATSUMURA Haruo的其他基金

相似基金

相关文献

中文摘要
翻译
本研究旨在探讨趋化因子CCL20-CCR6系统在沙门氏菌和其他微生物感染小鼠肠道和淋巴器官中的作用。本研究采用非免疫小鼠和经口免疫鼠伤寒沙门氏菌弱毒株的小鼠,分别分析了鼠伤寒沙门氏菌强毒株攻击后的初次免疫应答和二次免疫应答。在18种小鼠趋化因子受体中,29.2L17是针对CCR6的单抗,能够染色已知表达CCR6的正常小鼠淋巴样细胞。此外,29.2L17可用于免疫组织化学染色小鼠组织中表达CCR6的细胞。但29.2L17对小鼠CCR6没有明显的中和活性。我们建立了口服免疫和口服攻击鼠伤寒沙门氏菌的实验条件。在此条件下,在鼠伤寒沙门氏菌攻击前或攻击后的不同时间点,分别从对照组和免疫组小鼠的肠道、肝脏和脾组织中采集标本。这些组织有助于分析CCL20-CCR6系统在粘膜免疫中的初级和二级免疫反应中的作用。我们还在体外和体内证明了角膜上皮细胞和基质角质细胞产生CCL20的能力。通过建立单纯疱疹间质角膜炎的小鼠模型,发现不仅上皮细胞而且基质角质细胞在角膜中有效地产生CCL20,并将表达CCR6的细胞如树突状细胞募集到炎症的角膜中。
英文摘要
This research is to investigate the role of the chemokine CCL20-CCR6 system at intestine and lymphoid organ in mice infected with Salmonella and other microorganisms We used non-immune mice and mice immunized perorally with avirulent strain of Salmonella typhimurium for the analysis of primary immune response and secondary immune response, respectively, after challenge with the virulent strain of Salmonella typhimurium.Using immunized Armenian hamster spleen cells, we established anti-mouse CCR6 monoclonal antibody termed 29.2L17. The monoclonal antibody 29.2L17 was specific for CCR6 among the 18 mouse chemokine receptors and capable of staining normal mouse lymphoid cells known to expree CCR6. Furthermore, 29.2L17 could be used for staining cells expressing CCR6 in mouse tissues by immunohistochemistry. However, 29.2L17 does not have a significant neutralizing activity against mouse CCR6.We established experimental conditions for peroral immunization and peroral challenge of Salmonella typhimurium. Using these conditions, intestinal tract, liver and spleen were collected from control or immunized mice before or after the challenge with Salmonella typhimurium at several time points. These tissues are useful for the analysis of the role of the CCL20-CCR6 system in primary and secondary immune responses in the mucosal immunity.We have also demonstrated the ability of corneal epithelial cells and stromal keratocytes to produce CCL20 in vitro and in vivo. By using a mouse model of herpetic stromal keratatis, it has been revealed that not only epithelial cells but also stromal keratocytes efficiently produce CCL20 in the cornea and recruit cells expressing CCR6 such as dendritic sells into inflamed cornea.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Corneal epithelial cells and stromal keratocytes efficientl produce CC chemokine-ligand 20(CCL20) and attract cell expressing its receptor CCR6 in mouse herpetic stroma keratitis.
在小鼠疱疹性基质角膜炎中,角膜上皮细胞和基质角膜细胞有效产生CC趋化因子配体20(CCL20)并吸引表达其受体CCR6的细胞。
DOI: --
发表时间: 2004
期刊: Current Eye Research 28
影响因子: --
作者: [J.Shirane et al.]
通讯作者: J.Shirane et al.
Cutting Edge : Profile of chemokine receptor expression o human plasma cells accounts for their efficient recruitmen to target tissues.
前沿:人类浆细胞趋化因子受体表达概况解释了它们有效招募目标组织的原因。
DOI: --
发表时间: 2003
期刊: The Journal of Immunology 170
影响因子: --
作者: [Jumi Shirane, Takashi Nakayama, Daisuke Nagakubo, Dai Izawa, Kunio Hieshima, Yosikazu Shimomura, Osamu Yoshie, J.Shirane et al., T.Nakayama et al.]
通讯作者: T.Nakayama et al.
DOI: 10.4049/jimmunol.170.3.1136
发表时间: 2003-02-01
期刊: JOURNAL OF IMMUNOLOGY
影响因子: 4.4
作者: [Nakayama, T, Hieshima, K, Yoshie, O]
通讯作者: Yoshie, O
Corneal epithelial cells and stromal keratocytes efficiently produce CC chemokine-ligand 20 (CCL20) and attract cells expressing its receptor CCR6 in mouse herpetic stromal keratitis.
在小鼠疱疹性基质角膜炎中,角膜上皮细胞和基质角膜细胞有效产生 CC 趋化因子配体 20 (CCL20) 并吸引表达其受体 CCR6 的细胞。
DOI: --
发表时间: 2004
期刊: Current Eye Research vol.28
影响因子: --
作者: [Jumi Shirane, Takashi Nakayama, Daisuke Nagakubo, Dai Izawa, Kunio Hieshima, Yosikazu Shimomura, Osamu Yoshie]
通讯作者: Osamu Yoshie
Expression and function of structural proteins of paramyxovirus transcription complex
国内基金
海外基金
瘤内链球菌促进STAT3的O-GlcNAc修饰驱动鼻咽癌免疫抑制微环境的机制研究
  • 批准号:
    JCZRLH202600778
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
基于YF₃-Gd₂O₃体系的氮化铝陶瓷光固化成形与性能调控研究
  • 批准号:
    JCZRQNB202600614
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
多孔氮碳负载碱土金属修饰Cu/Cu₂O光催化CO₂还原及机理研究
  • 批准号:
    JCZRLH202601411
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
OSMI-4靶向O-糖基化调控PD-L1联合裂解OK-432协同治疗不完全消融后残存肝癌的机制研究
  • 批准号:
    JCZRLH202600261
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: